A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)
Zhang, L; Lu, S; Feng, J; Dechaphunkul, A; Chang, J; Wang, D; Chessari, S; Lanzarotti, C; Jordan, K; Aapro, M
- 期刊名称Annals of Oncology
- 作者Zhang, L; Lu, S; Feng, J; Dechaphunkul, A; Chang, J; Wang, D; Chessari, S; Lanzarotti, C; Jordan, K; Aapro, M
- 卷第29卷
- 期第2期
- 印刷ISSN0923-7534
- 电子ISSN1569-8041
- 文件大小362.66KB
- 发表时间2018-02-01
- DOI10.1093/annonc/mdx698
- 页码452-458